{"id":551987,"date":"2026-06-02T06:57:52","date_gmt":"2026-06-02T06:57:52","guid":{"rendered":"https:\/\/www.capgemini.com\/co-es\/?post_type=research-and-insight&#038;p=551987"},"modified":"2026-06-02T06:58:19","modified_gmt":"2026-06-02T06:58:19","slug":"nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica","status":"publish","type":"research-and-insight","link":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/","title":{"rendered":"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica"},"content":{"rendered":"\n<header class=\"wp-block-cg-blocks-hero-reusable header heroReusable  \"><div class=\"header-bgs\"><picture><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=2880&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 1500px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=1440&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=2880&amp;quality=70 2x\" media=\"(min-width: 992px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=1024&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=1024&amp;quality=70 2x\" media=\"(min-width: 768px)\"\/><source srcset=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=768&amp;quality=70 1x, https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg?w=768&amp;quality=70 2x\" media=\"(min-width: 0)\"\/><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Banner-Quantum-Pharma.jpg\" class=\"header-img header-img-d\" alt=\"\" style=\"object-fit:cover;object-position:50% 50%\" loading=\"eager\"\/><\/picture><\/div><div class=\"heroPictureCardHeaderShape\"><\/div><div class=\"container\"><div class=\"row\"><div class=\"col-md-12\"><div class=\"box\"><div class=\"boxTagWrapper\"><div class=\"tagInfo\"><div><span class=\"box-tag\">Health<\/span><\/div><\/div><div class=\"brandInfo\"><div class=\"brandLogo\"><img decoding=\"async\" loading=\"lazy\" src=\"\/wp-content\/themes\/capgemini2025\/assets\/images\/capgemini-invent-white.svg\" alt=\"capgemini-invent\" class=\"dark\"\/><img decoding=\"async\" loading=\"lazy\" src=\"\/wp-content\/themes\/capgemini2025\/assets\/images\/capgemini-invent.svg\" alt=\"capgemini-invent\" class=\"light\"\/><\/div><\/div><\/div><div class=\"box-title\"><h1 data-maxlength=\"34\">Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica<\/h1><\/div><div class=\"inner-row-insight download-btn\"><\/div><\/div><\/div><\/div><\/div><\/header>\n\n\n\n<section class=\"wp-block-cg-blocks-intro-para undefined section section--intro\"><div class=\"intro-para\"><div class=\"container\"><div class=\"row\"><div class=\"col-12 col-md-2\"><nav class=\"article-social\"><ul class=\"social-nav\"><li class=\"ip-order-fb\"><a href=\"https:\/\/www.facebook.com\/sharer\/sharer.php?u=https:\/\/www.capgemini.com\/co-es\/?post_type=research-and-insight&amp;p=551987\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Abrir en una nueva ventana\"><i aria-hidden=\"true\" class=\"icon-fb\"><\/i><span class=\"sr-only\">Facebook<\/span><\/a><\/li><li class=\"ip-order-li\"><a href=\"https:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.capgemini.com\/co-es\/?post_type=research-and-insight&amp;p=551987\" target=\"_blank\" rel=\"noopener noreferrer\" title=\"Abrir en una nueva ventana\"><i aria-hidden=\"true\" class=\"icon-li\"><\/i><span class=\"sr-only\">Linkedin<\/span><\/a><\/li><\/ul><\/nav><\/div><div class=\"col-12 col-md-8\"><h2 class=\"intro-para-title\">C\u00f3mo aprovechar la computaci\u00f3n cu\u00e1ntica para acelerar la investigaci\u00f3n traslacional y el desarrollo cl\u00ednico<br><\/h2><p class=\"intro-para-content\">Nos encontramos al borde de un avance trascendental en la computaci\u00f3n cu\u00e1ntica, uno en el que el n\u00famero de c\u00e1lculos por segundo aumenta de manera exponencial. Este incremento en la capacidad de c\u00f3mputo abre nuevas puertas para todas las industrias, pero especialmente para el sector farmac\u00e9utico. Basados \u200b\u200ben los principios de la mec\u00e1nica cu\u00e1ntica, estos ordenadores de pr\u00f3xima generaci\u00f3n aprovechan diversos tipos de algoritmos para llevar a cabo tareas de optimizaci\u00f3n cu\u00e1ntica, simulaci\u00f3n y aprendizaje autom\u00e1tico. Esto representar\u00e1 una revoluci\u00f3n en la I+D farmac\u00e9utica, al facilitar el modelado de fen\u00f3menos qu\u00edmicos y biol\u00f3gicos complejos, desde estructuras moleculares hasta el historial m\u00e9dico de los pacientes.<\/p><\/div><\/div><\/div><\/div><\/section>\n\n\n\n<section class=\"wp-block-cg-blocks-group undefined section section--article-content\"><div class=\"article-main-content\"><div class=\"container\"><div class=\"grid-container\"><div><div class=\"article-text article-quote-text\">\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p>\u201cLa computaci\u00f3n cu\u00e1ntica podr\u00eda acelerar la I+D farmac\u00e9utica al simular y predecir con mayor precisi\u00f3n los fen\u00f3menos biol\u00f3gicos y cl\u00ednicos vinculados a la salud humana.\u201d<\/p>\n<cite><em>S\u00e9bastien Tourlet, Director de Industria Inteligente y Ciencias de la Vida, Capgemini Invent<\/em><\/cite><\/blockquote>\n\n\n\n<figure class=\"wp-block-image size-full\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Graphic-Quantum-Pharma.jpg\" alt=\"\" class=\"wp-image-890744\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\">El ecosistema tecnol\u00f3gico sigue trabajando en un c\u00fabit m\u00e1s estable para avanzar hacia una computadora cu\u00e1ntica m\u00e1s fiable. La mayor\u00eda de las empresas a\u00fan buscan comprender c\u00f3mo se podr\u00eda aprovechar la tecnolog\u00eda cu\u00e1ntica.<\/td><td class=\"has-text-align-center\" data-align=\"center\">Ya est\u00e1 disponible un hardware cu\u00e1ntico m\u00e1s estable, tanto en las instalaciones como a trav\u00e9s de la nube. Las primeras aplicaciones ya se han comercializado y los pioneros est\u00e1n cosechando sus beneficios.<\/td><td class=\"has-text-align-center\" data-align=\"center\">Las computadoras cu\u00e1nticas est\u00e1n plenamente integradas en la pila tecnol\u00f3gica. Los c\u00fabits estabilizados permiten la implementaci\u00f3n de una amplia gama de aplicaciones en diversos sectores. Las empresas adquieren madurez en el aprovechamiento de la computaci\u00f3n cu\u00e1ntica.<\/td><\/tr><\/tbody><\/table><figcaption class=\"wp-element-caption\"><center>Cronolog\u00eda de las tecnolog\u00edas cu\u00e1nticas<\/center><\/figcaption><\/figure>\n\n\n\n<div style=\"height:40px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>En Capgemini, creemos que la computaci\u00f3n cu\u00e1ntica se utilizar\u00e1 para aumentar las tasas de \u00e9xito de los ensayos cl\u00ednicos. Una mayor capacidad de procesamiento dar\u00e1 lugar a un modelado avanzado de las enfermedades y de los efectos de los tratamientos a nivel gen\u00e9tico, celular, tisular, org\u00e1nico, individual y poblacional. Como resultado, pronto viviremos en un mundo con ensayos m\u00e1s optimizados y con cohortes de pacientes reducidas. Adem\u00e1s, el largo y complejo proceso de los ensayos podr\u00e1 agilizarse, lo que nos permitir\u00e1 reaccionar con mayor rapidez ante futuras crisis sanitarias y lograr nuevos avances en los tratamientos para las enfermedades existentes.<\/p>\n\n\n\n<div class=\"wp-block-media-text alignwide has-media-on-the-right is-stacked-on-mobile\" style=\"grid-template-columns:auto 57%\"><div class=\"wp-block-media-text__content\">\n<h4 class=\"wp-block-heading\" id=\"h-en-la-proxima-decada-el-descubrimiento-de-farmacos-y-el-desarrollo-clinico-podrian-acelerarse-drasticamente-gracias-a-la-computacion-cuantica\">En la pr\u00f3xima d\u00e9cada, el descubrimiento de f\u00e1rmacos y el desarrollo cl\u00ednico podr\u00edan acelerarse dr\u00e1sticamente gracias a la computaci\u00f3n cu\u00e1ntica.<\/h4>\n\n\n\n<div class=\"wp-block-buttons is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline\"><a class=\"wp-block-button__link wp-element-button\" href=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Quantum_computing-for-clinical-development.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Descarga el POV<\/a><\/div>\n<\/div>\n<\/div><figure class=\"wp-block-media-text__media\"><img decoding=\"async\" src=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Book-Quantum-Pharma.png?w=960\" alt=\"\" class=\"wp-image-890748 size-full\"\/><\/figure><\/div>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-calculos-cuanticos\"><strong>C\u00e1lculos cu\u00e1nticos<\/strong><\/h3>\n\n\n\n<p>La industria farmac\u00e9utica ya se est\u00e1 preparando para adoptar esta nueva tecnolog\u00eda revolucionaria, y con buena raz\u00f3n. Las cifras hablan por s\u00ed solas. La computaci\u00f3n cu\u00e1ntica har\u00e1 que el desarrollo de mol\u00e9culas sea mucho m\u00e1s econ\u00f3mico, mejorar\u00e1 la tasa de \u00e9xito de los ensayos cl\u00ednicos y, en general, acelerar\u00e1 todo el proceso de I+D.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table><tbody><tr><td class=\"has-text-align-center\" data-align=\"center\"><strong>USD 1.5+ BLN<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>7%<\/strong><\/td><td class=\"has-text-align-center\" data-align=\"center\"><strong>1.5 BLN times<\/strong><\/td><\/tr><tr><td class=\"has-text-align-center\" data-align=\"center\">El costo de llevar una nueva mol\u00e9cula al mercado (Wouters, McKee y Luyten, 2020)<\/td><td class=\"has-text-align-center\" data-align=\"center\">La probabilidad de lanzar el f\u00e1rmaco al iniciar los ensayos cl\u00ednicos de fase 1 es del 7% (Dowden &amp; Munro, 2019).<\/td><td class=\"has-text-align-center\" data-align=\"center\">Cu\u00e1nto m\u00e1s r\u00e1pidas son las computadoras cu\u00e1nticas que sus predecesoras (Google, 2019)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<div style=\"height:50px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p>Acelerar el descubrimiento de f\u00e1rmacos mediante la computaci\u00f3n cu\u00e1ntica implicar\u00eda cambios en las estrategias de gesti\u00f3n de carteras y una posible reinternalizaci\u00f3n de las actividades de investigaci\u00f3n. Pero el progreso y el cambio van de la mano.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-cuanto-vale-capgemini\"><strong>\u00bfCu\u00e1nto vale Capgemini?<\/strong><\/h3>\n\n\n\n<p>En Capgemini Invent, nos esforzamos por mantener a nuestros clientes a la vanguardia mediante investigaciones clave y perspectivas sobre tecnolog\u00edas de \u00faltima generaci\u00f3n, tales como las soluciones cu\u00e1nticas emergentes. Nuestro equipo de Ciencias de la Vida cuenta con una amplia experiencia global y est\u00e1 posicionado para ayudar a las empresas a aprovechar los nuevos enfoques cient\u00edficos, el an\u00e1lisis de datos y las capacidades digitales.<\/p>\n\n\n\n<p>Descubra c\u00f3mo el \u00e1mbito cu\u00e1ntico constituye un mundo totalmente nuevo de posibilidades a la espera de ser exploradas. Consulte nuestra \u00faltima publicaci\u00f3n: \u00ab<a href=\"https:\/\/www.capgemini.com\/wp-content\/uploads\/2023\/04\/Quantum_Pharma.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Nuevas bases para impulsar la I+D farmac\u00e9utica con la computaci\u00f3n cu\u00e1ntica<\/a>\u00bb y p\u00f3ngase en contacto con uno de nuestros expertos para profundizar a\u00fan m\u00e1s en el tema.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"<p>La computaci\u00f3n cu\u00e1ntica se utilizar\u00e1 pronto para acelerar la investigaci\u00f3n traslacional y el desarrollo cl\u00ednico. Descubra c\u00f3mo aprovechar la computaci\u00f3n cu\u00e1ntica para agilizar el proceso de transformar los hallazgos de la investigaci\u00f3n en tratamientos y curas.<\/p>\n","protected":false},"author":290,"featured_media":551988,"template":"","meta":{"cg_dt_proposed_to":[],"cg_seo_hreflang_relations":"[]","cg_seo_canonical_relation":"","cg_seo_hreflang_x_default_relation":"{\"uuid\":\"d0e92fc7-e43b-4dcd-886d-85dc76523c79\",\"blogId\":\"1\",\"domain\":\"www.capgemini.com\",\"sitePath\":\"\/\",\"postLink\":\"https:\/\/www.capgemini.com\/insights\/research-library\/new-grounds-for-boosting-pharmaceutical-rd-with-quantum-computing\/\",\"postId\":890696,\"isSaved\":true,\"isCrossLink\":false,\"hasCrossLink\":false,\"isEnabled\":true}","cg_dt_approved_content":true,"cg_dt_mandatory_content":false,"cg_dt_notes":"","cg_dg_source_changed":false,"cg_dt_link_disabled":false,"footnotes":"","related_resource_url":"","related_resource_id":0,"related_resource_size":"","related_resource_type":"","cg_author":0,"_yoast_wpseo_primary_theme":252,"primary_term":"Health","featured_focal_points":""},"tags":[],"research-and-insight-type":[78],"theme":[252],"brand":[79],"service":[],"industry":[119],"partners":[],"content-group":[],"class_list":["post-551987","research-and-insight","type-research-and-insight","status-publish","has-post-thumbnail","hentry","research-and-insight-type-point-of-view","theme-healthcare","brand-capgemini-invent","industry-life-sciences"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.8 (Yoast SEO v22.8) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica - Capgemini Colombia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.capgemini.com\/mx-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica\" \/>\n<meta property=\"og:description\" content=\"La computaci\u00f3n cu\u00e1ntica se utilizar\u00e1 pronto para acelerar la investigaci\u00f3n traslacional y el desarrollo cl\u00ednico. Descubra c\u00f3mo aprovechar la computaci\u00f3n cu\u00e1ntica para agilizar el proceso de transformar los hallazgos de la investigaci\u00f3n en tratamientos y curas.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/\" \/>\n<meta property=\"og:site_name\" content=\"Capgemini Colombia\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-02T06:58:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"627\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/\",\"name\":\"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica - Capgemini Colombia\",\"isPartOf\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg\",\"datePublished\":\"2026-06-02T06:57:52+00:00\",\"dateModified\":\"2026-06-02T06:58:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#breadcrumb\"},\"inLanguage\":\"es-MX\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es-MX\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#primaryimage\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg\",\"contentUrl\":\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg\",\"width\":2880,\"height\":1800},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.capgemini.com\/co-es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.capgemini.com\/co-es\/#website\",\"url\":\"https:\/\/www.capgemini.com\/co-es\/\",\"name\":\"Capgemini Colombia\",\"description\":\"Capgemini\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es-MX\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica - Capgemini Colombia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.capgemini.com\/mx-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/","og_locale":"es_MX","og_type":"article","og_title":"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica","og_description":"La computaci\u00f3n cu\u00e1ntica se utilizar\u00e1 pronto para acelerar la investigaci\u00f3n traslacional y el desarrollo cl\u00ednico. Descubra c\u00f3mo aprovechar la computaci\u00f3n cu\u00e1ntica para agilizar el proceso de transformar los hallazgos de la investigaci\u00f3n en tratamientos y curas.","og_url":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/","og_site_name":"Capgemini Colombia","article_modified_time":"2026-06-02T06:58:19+00:00","og_image":[{"width":1200,"height":627,"url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2025\/10\/New-Web-preview-global.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/","url":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/","name":"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica - Capgemini Colombia","isPartOf":{"@id":"https:\/\/www.capgemini.com\/co-es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#primaryimage"},"image":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#primaryimage"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg","datePublished":"2026-06-02T06:57:52+00:00","dateModified":"2026-06-02T06:58:19+00:00","breadcrumb":{"@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#breadcrumb"},"inLanguage":"es-MX","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/"]}]},{"@type":"ImageObject","inLanguage":"es-MX","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#primaryimage","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg","contentUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg","width":2880,"height":1800},{"@type":"BreadcrumbList","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.capgemini.com\/co-es\/"},{"@type":"ListItem","position":2,"name":"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica"}]},{"@type":"WebSite","@id":"https:\/\/www.capgemini.com\/co-es\/#website","url":"https:\/\/www.capgemini.com\/co-es\/","name":"Capgemini Colombia","description":"Capgemini","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.capgemini.com\/co-es\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es-MX"}]}},"theme_term_info":[{"id":252,"name":"Health"}],"industry_term_info":[{"id":119,"name":"Life sciences"}],"services_term_info":[],"partners_term_info":[],"brand_term_info":[{"id":79,"name":"Capgemini Invent","slug":"capgemini-invent"}],"brand_term":[{"id":79,"slug":"capgemini-invent"}],"parsely":{"version":"1.1.0","canonical_url":"https:\/\/capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/","smart_links":{"inbound":0,"outbound":0},"traffic_boost_suggestions_count":0,"meta":{"@context":"https:\/\/schema.org","@type":"NewsArticle","headline":"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica","url":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/","mainEntityOfPage":{"@type":"WebPage","@id":"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/"},"thumbnailUrl":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg?w=150&h=150&crop=1","image":{"@type":"ImageObject","url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg"},"articleSection":"Uncategorized","author":[],"creator":[],"publisher":{"@type":"Organization","name":"Capgemini Colombia","logo":""},"keywords":[],"dateCreated":"2026-06-02T06:57:52Z","datePublished":"2026-06-02T06:57:52Z","dateModified":"2026-06-02T06:58:19Z"},"rendered":"<meta name=\"parsely-title\" content=\"Nuevas bases para impulsar la I+D farmac\u00e9utica mediante la computaci\u00f3n cu\u00e1ntica\" \/>\n<meta name=\"parsely-link\" content=\"https:\/\/www.capgemini.com\/co-es\/insights\/biblioteca-de-investigacion\/nuevas-bases-para-impulsar-la-id-farmaceutica-mediante-la-computacion-cuantica\/\" \/>\n<meta name=\"parsely-type\" content=\"post\" \/>\n<meta name=\"parsely-image-url\" content=\"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg?w=150&amp;h=150&amp;crop=1\" \/>\n<meta name=\"parsely-pub-date\" content=\"2026-06-02T06:57:52Z\" \/>\n<meta name=\"parsely-section\" content=\"Uncategorized\" \/>","tracker_url":"https:\/\/cdn.parsely.com\/keys\/capgemini.com\/p.js"},"archive_status":false,"featured_image_src":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg","featured_image_alt":"","jetpack_sharing_enabled":true,"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Capgemini Colombia","distributor_original_site_url":"https:\/\/www.capgemini.com\/co-es","push-errors":false,"tag_names":[],"featured_image_url":"https:\/\/www.capgemini.com\/co-es\/wp-content\/uploads\/sites\/25\/2026\/06\/Banner-Quantum-Pharma.jpg","_links":{"self":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight\/551987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight"}],"about":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/types\/research-and-insight"}],"author":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/users\/290"}],"version-history":[{"count":1,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight\/551987\/revisions"}],"predecessor-version":[{"id":551989,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight\/551987\/revisions\/551989"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media\/551988"}],"wp:attachment":[{"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/media?parent=551987"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/tags?post=551987"},{"taxonomy":"research-and-insight-type","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/research-and-insight-type?post=551987"},{"taxonomy":"theme","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/theme?post=551987"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/brand?post=551987"},{"taxonomy":"service","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/service?post=551987"},{"taxonomy":"industry","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/industry?post=551987"},{"taxonomy":"partners","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/partners?post=551987"},{"taxonomy":"content-group","embeddable":true,"href":"https:\/\/www.capgemini.com\/co-es\/wp-json\/wp\/v2\/content-group?post=551987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}